Has come back (relapsed) within a year of treatment or does not go away (refractory) after your first treatment Has relapsed or is refractory and you cannot receive a hematopoietic stem cell ...

Breyanzi is a cell-based immunotherapy approved for treating certain kinds of B-cell lymphoma in adults. It’s used in situations where cancer has come back after past treatment or is not responding to ...

Breyanzi has the potential to be the first and only CAR T cell therapy approved for MZL, addressing a high unmet need Application based on results from MZL cohort of TRANSCEND FL presented at ICML in ...

Breyanzi is a type of cancer treatment known as CAR T-cell therapy. Common side effects include fatigue, fever, and chills. Serious side effects, such as cytokine release syndrome (CRS), are also ...

Breyanzi (lisocabtagene maraleucel) is a type of cancer treatment known as CAR T-cell therapy. Its side effects range from mild and easy to manage to serious, needing emergency treatment. Breyanzi is ...